Pfizer Drug Shows Mixed Results in Psoriasis Trials

A high dose of Pfizer’s tofacitinib has proven as effective as Enbrel in treating psoriasis, while a lower dose proved less effective. The results suggest that the drug would not be in high demand after the study.
Reuters